Cannabinoids in pediatrics

Christopher T. Campbell, Marjorie Shaw Phillips, Kalen Manasco

Research output: Contribution to journalReview articlepeer-review

49 Scopus citations

Abstract

Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.

Original languageEnglish (US)
Pages (from-to)176-185
Number of pages10
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume22
Issue number3
DOIs
StatePublished - May 1 2017
Externally publishedYes

Keywords

  • CBD
  • Cannabidiol
  • Cannabis
  • Epilepsy
  • Pediatrics
  • Pharmacy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Cannabinoids in pediatrics'. Together they form a unique fingerprint.

Cite this